COMMUNIQUÉS West-GlobeNewswire

Arch Therapeutics to Provide Corporate Update at the 30th Annual Roth Conference on March 12, 2018
05/03/2018
FRAMINGHAM, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a [...]
Aeterna Zentaris Provides Update on Previously Disclosed Class Action Lawsuit
05/03/2018
CHARLESTON, S.C., March 05, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (the “Company” or “Aeterna Zentaris”) (NASDAQ: AEZS ) and (TSX: AEZS ) announced today that the United States District Court for the District of [...]
Strongbridge Biopharma plc to Present KEVEYIS® (dichlorphenamide) Primary Periodic Paralysis Data at the 2018 American Academy of Neurology Annual Meeting
05/03/2018
~ Post-Hoc Analysis of Phase 3 Placebo-Controlled Study of KEVEYIS Showed Adolescents had Similar Improvements in Short-Term Attack Rates as Adults ~ ~ Pooled Analysis of Two Phase 3 Studies Further Demonstrate the [...]
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2018
05/03/2018
CRANBURY, N.J., March 05, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) today announced upcoming presentations at two investor conferences in March. John F. Crowley, Chairman and Chief Executive Officer, [...]
FDA Approves PDUFA Fee Waiver for Gimoti™ New Drug Application
05/03/2018
SOLANA BEACH, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK ), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the U.S. [...]
Vericel Reports Fourth Quarter and Year End 2017 Financial Results and Provides Full Year 2018 Financial Guidance
05/03/2018
Record Quarterly Revenues of $23.4 Million Represent a 41% Increase Over Fourth Quarter 2016 Positive Operating and Net Income Reported for the Fourth Quarter Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass [...]
Conatus Pharmaceuticals to Highlight Anticipated Clinical Data Readouts at Upcoming Investor Conferences
05/03/2018
SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) -- At three upcoming investor conferences in March, Conatus Pharmaceuticals Inc. (NASDAQ: CNAT ) President, Chief Executive Officer and co-founder, Steven J. Mento, Ph.D., and [...]
Actinium Announces $15.4 Million in Expected Gross Proceeds from Recently Expired Rights Offering
05/03/2018
NEW YORK, March 05, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) ("Actinium" or "the Company") announced today that the Company’s previously announced rights offering (“the Rights [...]
Zealand Pharma to present at the Cowen & Co. Health Care Conference, March 12, 2018 in Boston
05/03/2018
Press release - No. 06 / 2018 Zealand Pharma to present at the Cowen & Co. Health Care Conference, March 12, 2018 in Boston Copenhagen, March 5, 2018 - Britt Meelby Jensen, President and Chief Executive Officer (CEO [...]
Biohit Oyj - Managers' Transactions
05/03/2018
Biohit Oyj - Managers' Transactions, March 5, 2018 at 2:10 pm local time (EEST) Biohit Oyj has received the following notification. Biohit Oyj - Managers' Transactions ____________________________________________ Person [...]
Agios to Present at the Cowen 38th Annual Healthcare Conference Monday, March 12, 2018
05/03/2018
CAMBRIDGE, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO ), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company [...]
SHIRE LAUNCHES MYPKFIT(TM) FOR ADVATE® [ANTIHEMOPHILIC FACTOR (RECOMBINANT)] IN THE U.S.
05/03/2018
SHIRE LAUNCHES MYPKFIT (TM) FOR ADVATE ® [ANTIHEMOPHILIC FACTOR (RECOMBINANT)] IN THE U.S. First and only FDA-cleared PK dosing software now available to help healthcare professionals create personalized treatment [...]
Horizon Discovery hosts Capital Markets Day today
05/03/2018
Horizon Discovery Group plc Horizon Discovery hosts Capital Markets Day today Cambridge, UK, 5 March 2018: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or "the Group"), a global leader in gene editing and gene [...]
BioDelivery Sciences to Present at the 30th Annual ROTH Conference
05/03/2018
RALEIGH, N.C., March 05, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI ), a specialty pharmaceutical company with a focus in pain management and addiction medicine, today announced that [...]
Lexington Cardiovascular Health Monitor Performing as Designed with First Clinical Patients
05/03/2018
VANCOUVER, British Columbia, March 05, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is pleased to provide an [...]
Medibio signs binding term sheet to acquire Vital Conversations
05/03/2018
Capitalizes on 3 years of partnership success in Corporate Health programs Appoints Peta Slocombe, founder of Australia’s Biggest Mental Health Check-In, to lead Medibio Corporate Health Strategic Business Unit [...]
Ossur Hf : Candidates to the Board of Directors
05/03/2018
Announcement no. 14/2018 Reykjavik, 5 March 2018 Candidates to the Board of Directors Enclosed details on the candidates to the Board of Directors of Össur hf., to be elected at the Company's Annual General Meeting held [...]
Santhera Reports Outcome of Exploratory Trial with Idebenone in PPMS Conducted at the NIH
05/03/2018
Pratteln, Switzerland, March 5, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that the exploratory Phase I/II clinical trial in primary progressive multiple sclerosis (PPMS) conducted as an investigator- [...]
Addex Secures Investor Commitment for CHF40 million Capital Increase Following Successful Completion of Book Building Process
05/03/2018
Geneva, Switzerland, 5 March 2018 - Addex Therapeutics (SIX: ADXN), the leading developer of oral allosteric modulators for neurological disorders, announced today that the Company has secured investor commitments for [...]

Pages